Pursuant to the Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( Listing Regulations ) read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 with respect to the change in Senior Management Personnel, we would like to inform the exchanges that Dr. Trissa Joseph, Vice President R & D of the Company has resigned from the said position with effect from the close of working hours of September 30, 2026 due to personal reasons. The resignation email tendered by Dr. Trissa Joseph is enclosed.
According to primary filings and dispatches highlighted by NSE India, the latest move impacts key counters including relevant market segments. Market analysts note that volume activity and corporate disclosures indicate significant retail and domestic institutional engagement with the development.
Traders are proceeding with cautious positioning as downside risks and profit-booking pressures are closely monitored across market segments. Risk management parameters suggest awaiting clear base-building signals before taking fresh directional exposure.
Investors and intraday participants are advised to monitor official exchange disclosures on BSE and NSE, alongside subsequent management commentary. ZeroLive will continue monitoring real-time order book developments, price action triggers, and regulatory updates as they unfold.